1. Home
  2. ADAP

as 05-22-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Founded: 2008 Country:
United Kingdom
United Kingdom
Employees: N/A City: ABINGDON, OXFORDSHIRE
Market Cap: 276.0M IPO Year: 2015
Target Price: $4.67 AVG Volume (30 days): 1.4M
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.66 EPS Growth: N/A
52 Week Low/High: $0.42 - $2.05 Next Earning Date: 05-15-2024
Revenue: $18,358,000 Revenue Growth: -74.21%
Revenue Growth (this year): 18.52% Revenue Growth (next year): -8.68%

Share on Social Networks:

Stock Insider Trading Activity of Adaptimmune Therapeutics plc (ADAP)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 16 '24 Sell $0.67 13,599 $9,152.13 20,201 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 16 '24 Sell $0.67 5,309 $3,572.96 7,785 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 16 '24 Sell $0.79 4,681 $3,697.99 7,023 SEC Form 4
Rawcliffe Adrian ADAP Chief Executive Officer Jan 16 '24 Sell $0.79 9,304 $7,350.16 14,104 SEC Form 4
Rawcliffe Adrian ADAP Chief Executive Officer Jan 16 '24 Sell $0.67 30,080 $20,243.84 44,848 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 16 '24 Sell $0.79 4,681 $3,697.99 7,023 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 16 '24 Sell $0.67 5,309 $3,572.96 7,785 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 16 '24 Sell $0.67 12,805 $8,617.77 19,015 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 11 '24 Sell $0.85 5,220 $4,458.40 7,874 SEC Form 4
Lunger John ADAP Chief Patient Supply Officer Jan 11 '24 Sell $0.84 4,009 $3,354.33 6,104 SEC Form 4
Rawcliffe Adrian ADAP Chief Executive Officer Jan 11 '24 Sell $0.85 17,257 $14,739.20 26,388 SEC Form 4
Rawcliffe Adrian ADAP Chief Executive Officer Jan 11 '24 Sell $0.84 11,945 $9,994.38 18,395 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 11 '24 Sell $0.84 4,009 $3,354.33 6,104 SEC Form 4
Bertrand William C JR ADAP Chief Operating Officer Jan 11 '24 Sell $0.85 5,220 $4,458.40 7,874 SEC Form 4